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Amphotericin B Washout of Fungal Peritonitis in Liver Transplant Recipient
Ann Thompson, D.O., Mara Piltin D.O., Alyssa Imperatore, D.O., Ely Sebastian, M.D. Sandra Paluzzi M.D..
                                                       Our Lady of Lourdes Medical Center.
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Invasive fungal infection (IFI) has been shown to have 
significant prevalence as well as morbidity and 
mortality among the organ transplant recipient 
population. From 2001-2006 a prospective 
surveillance study consisting of 15 US transplant 
centers was conducted resulting in screening of 
18,000 transplant recipients with identification of 1208 
patients with invasive fungal infections. The pertinent 
results of the study showed an increase in fungal 
infections during the period of the study with an aim at 
focusing on the incidence, timing and mortality to 
improve prevention and treatment (1). From 
2003-2012 a retrospective study identified 120 liver 
transplant recipients of which 13.5% were shown to 
have fungal infections (2). A review paper found a 
range in the literature of 5-42% of patients having at 
least one fungal infection post-transplant (3). 
Fungal peritonitis is often difficult to diagnosis early 
due to lack of symptoms or specific clinical findings. 
Studies have shown that fungal infections usually 
occur within the first 3 months of liver transplantation. 
(1,4). The risk factors identified are multiple including, 
long continuous parenteral nutrition time, poorly 
controlled high blood sugar, long-term mechanical 
ventilation, rejection treatment, cytomegalovirus (CMV) 
viremia or disease, acute hepatic insufficiency, early 
graft failure, re-transplantation, prolonged preoperative 
hospitalization (particularly in the intensive care unit 
(ICU), preoperative use of broad-spectrum antibiotics, 
fungal colonization (2). A study with 152 liver recipients 
identified 2 independent risk factors for IFI as renal 
insufficiency requiring CVV or HD and correlation with 
the amount of fresh frozen plasma transfused (4). A 
review of 10 centers in Europe over 3 years in which 
1208 liver transplants were performed resulted in 42 
invasive fungal infections identified. The most 
significant risk factors were found to be respectively 
re-operation, presence of choledocojejunostomy and 
initial operating time of >8hrs (5).
Index Operation: Orthotopic liver transplant with 
roux en y choledocojejunostomy biliary 
reconstruction and placement of gastrojejunostomy 
tube-Transfused 20UPRBC, 6FFP, 2 Platelets, 1 
Cryo
POD 9 Dx Hand assisted laparoscopy for peritonitis, 
enterotomy with primary repair, revision 
reinforcement of jejunojejunostomy anastomosis
POD 22 Exploratory Laparotomy, saline washout, 
small bowel resection, removal of gastrojejunostomy 
tube, liver biopsy, placement of Abthera Vac
POD 24 Exploratory Laparotomy, saline washout, 
creation of end ileostomy, Dobhoff tube, 
Amphotericin B Dwell (30 min), Abthera Vac
POD 26 Exploratory Laparotomy, Saline washout, 
Right hemicolectomy, Amphotericin B Dwell (30 
min), Abdominal wall closure with Wound Vac 
placement
POD 41 Sacral Wound Debridement 
POD 103 Diagnostic Laparoscopy, Stamm 
Gastrojejunostomy feeding tube, EGD
POD 174 Exploratory Laparotomy, Ileostomy 
Takedown with Ileocolonic Anastomosis
The patient progressed well after resolution of fungal 
infection and was at acute rehab at one point. 
However, now has returned to inpatient status.
Invasive fungal infection still carries high morbidity 
and mortality among organ transplant recipients 
despite advances in techniques, medical care and 
immunosuppression
It is reasonable based on prior studies showing 
success with abdominal washout and multiple uses 
of topical antifungal medications to use a multimodal 
approach with both intravenous medication and 
topical application of amphotericin B. The transplant 
patient is at higher of risk of complications due to 
immunosuppression and often multiple 
co-morbidities and/or malnutrition.This patient 
population should be considered for aggressive 
treatment measures with any complication.  
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HPI: A 64 y/o female presented electively for 
orthotopic liver transplant.
 
Allergies: NKDA
PMH: Cirrhosis, Hepatitis C, GERD, Bacterial 
peritonitis
PSH: Cesarean section, Ventral hernia repair, 
Multiple paracentesis
Social Hx: Former smoker, No ETOH or Drug use
Fam Hx: Non-contributory
Pertinent clinical information: 
-Poor nutrition
-Chronic hyponatremia
-Nephrology recommendations for CVVHD in the
       OR until reperfusion of transplanted liver
1
Intervention and Rationale     
The patient continued to have significant ascites, 
requiring paracentesis which showed profound 
PMNs, signifying what was originally thought to be 
a secondary bacterial peritonitis with staph 
epidermidis from the cultures as a morbidity of the 
liver transplant however, further cultures resulted 
in identification of Candida species
A meta-analysis of 23 papers noted that abdominal 
washout with antibiotics compared to saline 
showed a significant decrease in morbidity (12).
Previous studies have also shown some 
successes with using direct application of 
antifungal medications including anti-fungal 
medication washout in patients with peritoneal 
dialysis catheters developing fungal peritonitis and 
also using antifungals for bladder irrigation in 
candiduria as well as intra-vitreal injections for 
fungal endophthalmitis (13,14).
An intraoperative discussion with the infectious 
disease team lead to the decision to use an 
amphotericin dwell during abdominal washout.
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